BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World J Gastroenterol 2008; 14(37): 5665-5673 [PMID: 18837082 DOI: 10.3748/wjg.14.5665]
URL: https://www.wjgnet.com/1007-9327/full/v14/i37/5665.htm
Number Citing Articles
1
Hong Liu, Yan Ma, Hong-Wei He, Wu-Li Zhao, Rong-Guang Shao. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cellsAutophagy 2017; 13(5): 900 doi: 10.1080/15548627.2017.1291479
2
Yuzo Fujikura, J. Krijt, C. Povýšil, Z. Mělková, P. Přikryl, M. Vokurka, E. Nečas. Iron Overload Causes Alterations of E-Cadherin in the LiverFolia Biologica 2016; 62(3): 95 doi: 10.14712/fb2016062030095
3
Franziska van Zijl, Gudrun Zulehner, Michaela Petz, Doris Schneller, Christoph Kornauth, Mara Hau, Georg Machat, Markus Grubinger, Heidemarie Huber, Wolfgang Mikulits. Epithelial–Mesenchymal Transition in Hepatocellular CarcinomaFuture Oncology 2009; 5(8): 1169 doi: 10.2217/fon.09.91
4
Florence Grise, Sandra Sena, Aurélien Bidaud-Meynard, Jessica Baud, Jean-Baptiste Hiriart, Kassem Makki, Nathalie Dugot-Senant, Cathy Staedel, Paulette Bioulac-Sage, Jessica Zucman-Rossi, Jean Rosenbaum, Violaine Moreau. Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasionHepatology 2012; 55(6): 1766 doi: 10.1002/hep.25568
5
Kosha J. Mehta, Paul A. Sharp. Iron elevates mesenchymal and metastatic biomarkers in HepG2 cellsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78348-5
6
Man Li, Hailing Lu, Xiaolian Liu, Qingwei Meng, Yanbin Zhao, Xuesong Chen, Jing Hu, Wei Liu, Li Cai. Overexpression of 14‑3‑3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinomaOncology Letters 2018;  doi: 10.3892/ol.2018.8742
7
Dong Chen, Yan Wang, Kejun Zhang, Xuelong Jiao, Bomin Yan, Jun Liang. Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-CadherinInternational Journal of Molecular Sciences 2012; 13(8): 10594 doi: 10.3390/ijms130810594
8
Lili Zhou, Tirthadipa Pradhan-Sundd, Minakshi Poddar, Sucha Singh, Alex Kikuchi, Donna B. Stolz, Weinian Shou, Zongfang Li, Kari N. Nejak-Bowen, Satdarshan P. Monga. Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical CarcinogenesisThe American Journal of Pathology 2015; 185(12): 3274 doi: 10.1016/j.ajpath.2015.08.019
9
Alexandros Charalabopoulos, Christos Golias. E-cadherin expression in Barrett’s esophagus and esophageal carcinomaEsophagus 2014; 11(3): 153 doi: 10.1007/s10388-014-0424-x
10
Shuhua Zhao, Yuanyuan Zhang, Xiuxiu Zheng, Xiaolong Tu, Huanan Li, Jiangning Chen, Yuhui Zang, Junfeng Zhang. Loss of MicroRNA‐101 Promotes Epithelial to Mesenchymal Transition in HepatocytesJournal of Cellular Physiology 2015; 230(11): 2706 doi: 10.1002/jcp.24995
11
Liang-yun Li, Jun-fa Yang, Fan Rong, Zhi-pan Luo, Shuang Hu, Hui Fang, Ying Wu, Rui Yao, Wei-hao Kong, Xiao-wen Feng, Bang-jie Chen, Jun Li, Tao Xu. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathwayActa Pharmacologica Sinica 2021; 42(10): 1676 doi: 10.1038/s41401-020-00575-3
12
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognosticationChinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
13
Tamara M H Gall, Adam E Frampton. Gene of the month: E-cadherin (CDH1)Journal of Clinical Pathology 2013; 66(11): 928 doi: 10.1136/jclinpath-2013-201768
14
Antonio Saviano, Natascha Roehlen, Alessia Virzì, Armando Andres Roca Suarez, Yujin Hoshida, Joachim Lupberger, Thomas F. Baumert. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 317 doi: 10.1007/978-3-030-21540-8_15
15
Berik Rovgaliyev, Ming Yuan Tan, Kwang-Woong Lee, Seung Cheol Oh, Min Young Park, Sooin Seo, Hyo-Sun Choi, Suk Kyun Hong, Jae-Hyung Cho, Jeong-Moo Lee, Nam-Joon Yi, Kyung-Suk Suh. Sirolimus Attenuates Calcineurin Inhibitor-Induced Epithelial-Mesenchymal Transition in Hepatocellular CarcinomaTransplantation Proceedings 2022; 54(7): 2025 doi: 10.1016/j.transproceed.2022.04.027
16
Junfeng Li, Xiaopeng Dai, Hongfei Zhang, Wei Zhang, Shihui Sun, Tongtong Gao, Zhihua Kou, Hong Yu, Yan Guo, Lanying Du, Shibo Jiang, Jianying Zhang, Yusen Zhou. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherinOncotarget 2015; 6(30): 29196 doi: 10.18632/oncotarget.5039
17
Nathalie Zucchini-Pascal, Ludovic Peyre, Roger Rahmani. Crosstalk between Beta-Catenin and Snail in the Induction of Epithelial to Mesenchymal Transition in Hepatocarcinoma: Role of the ERK1/2 PathwayInternational Journal of Molecular Sciences 2013; 14(10): 20768 doi: 10.3390/ijms141020768
18
Hyunkyoung Lee, Min Jung Pyo, Seong Kyeong Bae, Yunwi Heo, Indu Choudhary, Duhyeon Hwang, Hyeryeon Yang, Je-hein Kim, Jinho Chae, Chang Hoon Han, Changkeun Kang, Seungshic Yum, Euikyung Kim. Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial–mesenchymal transition in HepG2 cellsScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20724-3
19
Xuejun Kuang, Jiye Zhu, Zhao Peng, Jianjun Wang, Zhigang Chen. Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial–Mesenchymal Transition in Hepatocellular CarcinomaDigestive Diseases and Sciences 2016; 61(2): 489 doi: 10.1007/s10620-015-3879-2
20
Lili Wang, Lexun Xue, Hongxia Yan, Jie Li, Yucheng Lu. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cellsMolecular Biology Reports 2010; 37(4): 1971 doi: 10.1007/s11033-009-9645-9
21
Vladimír Bartoš, Milada Kullová. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the SkinActa Medica (Hradec Kralove, Czech Republic) 2017; 60(1): 32 doi: 10.14712/18059694.2017.48
22
Mary E. Landmesser, Wesley M. Raup-Konsavage, Heather L. Lehman, Douglas B. Stairs, Claudia D. Andl. Loss of p120ctn causes EGFR-targeted therapy resistance and failurePLOS ONE 2020; 15(10): e0241299 doi: 10.1371/journal.pone.0241299
23
Bang-Hao Xu, Jing-Hang Jiang, Tao Luo, Zhi-Jun Jiang, Xin-Yu Liu, Le-Qun Li. Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinomaMedicine 2021; 100(30): e26762 doi: 10.1097/MD.0000000000026762
24
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
25
Igor P. Pogribny, Ivan Rusyn. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinomaCancer Letters 2014; 342(2): 223 doi: 10.1016/j.canlet.2012.01.038
26
Anja Konzack, Mirza Jakupovic, Kateryna Kubaichuk, Agnes Görlach, Frank Dombrowski, Ilkka Miinalainen, Raija Sormunen, Thomas Kietzmann. Mitochondrial Dysfunction Due to Lack of Manganese Superoxide Dismutase Promotes HepatocarcinogenesisAntioxidants & Redox Signaling 2015; 23(14): 1059 doi: 10.1089/ars.2015.6318
27
Xin Chen, Hong Wang, Dandan Li, Yuan Yu, Jinfang Zhi. The effect of carboxylated nanodiamond (cNDs) on the migration of HepG2 cellsphysica status solidi (a) 2016; 213(8): 2131 doi: 10.1002/pssa.201600094
28
J. Sun, D. Zhang, D.-H. Bae, S. Sahni, P. Jansson, Y. Zheng, Q. Zhao, F. Yue, M. Zheng, Z. Kovacevic, D. R. Richardson. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motorsCarcinogenesis 2013; 34(9): 1943 doi: 10.1093/carcin/bgt163
29
Simona Gurzu, Laszlo Kobori, Decebal Fodor, Ioan Jung. Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A ReviewBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2962580
30
Nanhong Tang, Qun Xie, Xiaoqian Wang, Xiujin Li, Yanlin Chen, Xu Lin, Jianyin Lin. Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and Epithelial-Mesenchymal TransitionArchives of Pharmacal Research 2011; 34(5): 781 doi: 10.1007/s12272-011-0512-6
31
D. Firrincieli, M. Boissan, N. Chignard. Epithelial-mesenchymal transition in the liverGastroentérologie Clinique et Biologique 2010; 34(10): 523 doi: 10.1016/j.gcb.2010.04.017
32
Yuehua Zhao, Hao Lin, Jingwei Jiang, Mengxi Ge, Xiaohua Liang. TBL1XR1 as a potential therapeutic target that promotes epithelial‑mesenchymal transition in lung squamous cell carcinomaExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6955
33
Abdel Hady A. Abdel Wahab, Manal M. Hussein, Samia A. Shouman, Dalia Fouad, Mohamed H. Kobaisi, Ola EL Habit. Role of let7-g and miR-221 level as potential predictors for overall survival of hepatocellular carcinoma patientsArab Journal of Gastroenterology 2022; 23(3): 151 doi: 10.1016/j.ajg.2022.03.001
34
Carolina Noronha, Ana Sofia Ribeiro, Ricardo Taipa, Diogo S. Castro, Joaquim Reis, Cláudia Faria, Joana Paredes. Cadherin Expression and EMT: A Focus on GliomasBiomedicines 2021; 9(10): 1328 doi: 10.3390/biomedicines9101328
35
Jolanda van Hengel, Celine Van den Broeke, Tim Pieters, Louis Libbrecht, Ilse Hofmann, Frans van Roy. Inactivation of p120 catenin in mice disturbs intrahepatic bile duct development and aggravates liver carcinogenesisEuropean Journal of Cell Biology 2016; 95(12): 574 doi: 10.1016/j.ejcb.2016.10.003
36
Longbo Zheng, Ming Xu, Junjie Xu, Ke Wu, Qian Fang, Yuelong Liang, Senjun Zhou, Dong Cen, Lin Ji, Weili Han, Xiujun Cai. ELF3 promotes epithelial–mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinomaCell Death & Disease 2018; 9(3) doi: 10.1038/s41419-018-0399-y
37
Sajith Nair, Devaki S Arathy, Aneesh Issac, Easwaran Sreekumar. Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte culturesVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-363
38
Svetlana N. Rubtsova, Irina Y. Zhitnyak, Natalya A. Gloushankova. Phenotypic Plasticity of Cancer Cells Based on Remodeling of the Actin Cytoskeleton and Adhesive StructuresInternational Journal of Molecular Sciences 2021; 22(4): 1821 doi: 10.3390/ijms22041821
39
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsOncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
40
Jiang Chen, Jinghua Liu, Renan Jin, Jiliang Shen, Yuelong Liang, Rui Ma, Hui Lin, Xiao Liang, Hong Yu, Xiujun Cai, Andreas Krieg. Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-AnalysisPLoS ONE 2014; 9(11): e111885 doi: 10.1371/journal.pone.0111885
41
Huakan Zhao, Fenglin Lv, Guizhao Liang, Xiaobin Huang, Gang Wu, Wenfa Zhang, Le Yu, Lei Shi, Yong Teng. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activationOncotarget 2016; 7(12): 13575 doi: 10.18632/oncotarget.6185
42
Luc Gailhouste. Liver Stem CellsMethods in Molecular Biology 2012; 826: 33 doi: 10.1007/978-1-61779-468-1_4
43
Heather L. Lehman, Michal Kidacki, Douglas B. Stairs. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytesScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75866-0
44
Xianteng Wang, Hao Wang, Guosheng Li, Yonghong Song, Shurong Wang, Faliang Zhu, Chun Guo, Lining Zhang, Yongyu Shi. Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF–κB/Slug pathwayTumor Biology 2014; 35(9): 8893 doi: 10.1007/s13277-014-2159-7
45
Gerhard F Huber, Lena Züllig, Alex Soltermann, Matthias Roessle, Nicole Graf, Stephan K Haerle, Gabriela Studer, Wolfram Jochum, Holger Moch, Sandro J Stoeckli. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynxBMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-217
46
Michal Kielbik, Izabela Szulc-Kielbik, Magdalena Klink. E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian CancerInternational Journal of Molecular Sciences 2022; 23(22): 14383 doi: 10.3390/ijms232214383
47
Rachel Purcell, Margaret Childs, Rudolf Maibach, Carina Miles, Clinton Turner, Arthur Zimmermann, Piotra Czauderna, Michael Sullivan. Potential biomarkers for hepatoblastoma: Results from the SIOPEL-3 studyEuropean Journal of Cancer 2012; 48(12): 1853 doi: 10.1016/j.ejca.2011.10.019
48
María L. Bacigalupo, Malena Manzi, María V. Espelt, Lucas D. Gentilini, Daniel Compagno, Diego J. Laderach, Carlota Wolfenstein‐Todel, Gabriel A. Rabinovich, María F. Troncoso. Galectin‐1 Triggers Epithelial‐Mesenchymal Transition in Human Hepatocellular Carcinoma CellsJournal of Cellular Physiology 2015; 230(6): 1298 doi: 10.1002/jcp.24865
49
Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng. Heterogeneity of hepatocellular carcinoma contributes to cancer progressionCritical Reviews in Oncology/Hematology 2015; 94(3): 337 doi: 10.1016/j.critrevonc.2015.01.009
50
Emily Diane Wickline, Yu Du, Donna B. Stolz, Michael Kahn, Satdarshan P.S. Monga. γ-Catenin at Adherens Junctions: Mechanism and Biologic Implications in Hepatocellular Cancer after β-Catenin KnockdownNeoplasia 2013; 15(4): 421 doi: 10.1593/neo.122098
51
Subhayan Sur, Debolina Pal, Kaustav Banerjee, Suvra Mandal, Ashes Das, Anup Roy, Chinmay Kumar Panda. Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse modelMolecular Carcinogenesis 2016; 55(7): 1138 doi: 10.1002/mc.22356
52
A.L. Jones, A. Suárez-Bonnet, J.A. Mitchell, G.A. Ramirez, M.F. Stidworthy, S.L. Priestnall. Avian Papilloma and Squamous Cell Carcinoma: a Histopathological, Immunohistochemical and Virological studyJournal of Comparative Pathology 2020; 175: 13 doi: 10.1016/j.jcpa.2019.11.007
53
Jiřina Procházková, Markéta Kabátková, Lenka Šmerdová, Jiří Pacherník, Dominika Sýkorová, Jiří Kohoutek, Pavlína Šimečková, Eva Hrubá, Alois Kozubík, Miroslav Machala, Jan Vondráček. Aryl Hydrocarbon Receptor Negatively Regulates Expression of the Plakoglobin Gene (Jup)Toxicological Sciences 2013; 134(2): 258 doi: 10.1093/toxsci/kft110
54
Cong-Li Jia, Fu Yang, Rui-Ning Li. Identification of Potential Core Genes Between Primary and Metastatic Malignant Melanoma and Analysis of Their Immune CorrelationInternational Journal of General Medicine 2022; : 379 doi: 10.2147/IJGM.S338890
55
Hye-Sun Choi, Seon-Hee Yim, Hai-Dong Xu, Seung-Hyun Jung, Seung-Hun Shin, Hae-Jin Hu, Chan-Kwon Jung, Jong Young Choi, Yeun-Jun Chung. Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinomaBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-122
56
Fausto J. Rodriguez, Laura J. Lewis-Tuffin, Panos Z. Anastasiadis. E-cadherin's dark side: Possible role in tumor progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1826(1): 23 doi: 10.1016/j.bbcan.2012.03.002
57
Luis Fernando Méndez-López, Ana Laura de la Garza Hernández, Manuel López-Cabanillas Lomelí. Interdisciplinary Cancer Research 2024;  doi: 10.1007/16833_2024_324
58
Jennifer Pasquier, Nadine Abu-Kaoud, Haya Al Thani, Arash Rafii. Epithelial to Mesenchymal Transition in a Clinical PerspectiveJournal of Oncology 2015; 2015: 1 doi: 10.1155/2015/792182
59
Agnieszka Dominiak, Beata Chełstowska, Wioletta Olejarz, Grażyna Nowicka. Communication in the Cancer Microenvironment as a Target for Therapeutic InterventionsCancers 2020; 12(5): 1232 doi: 10.3390/cancers12051232
60
Mohan Krishna Ghanta, Mohammad Faiz Hussain, Asmita Karnalkar, Sirpu Natesh Nagabhishek, Poojith Nuthalapati, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 401 doi: 10.1016/B978-0-323-99283-1.00003-3
61
Natalya A. Gloushankova, Svetlana N. Rubtsova, Irina Y. Zhitnyak. Cadherin-mediated cell-cell interactions in normal and cancer cellsTissue Barriers 2017; 5(3): e1356900 doi: 10.1080/21688370.2017.1356900
62
Jiang Chen, Jie Zhao, Rui Ma, Hui Lin, Xiao Liang, Xiujun Cai, Kwan Man. Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-AnalysisPLoS ONE 2014; 9(8): e103952 doi: 10.1371/journal.pone.0103952